Synthesis of pseudoxazolones and their inhibition of the 3C cysteine proteinases from hepatitis A virus and human rhinovirus-14

被引:9
作者
Ramtohul, YK
Martin, NI
Silkin, L
James, MNG
Vederas, JC [1 ]
机构
[1] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada
[2] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada
来源
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1 | 2002年 / 11期
关键词
D O I
10.1039/b202643k
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The hepatitis A virus (HAV) and human rhinovirus (HRV) are important pathogens that belong to the picornavirus family. All picornaviruses have a 3C proteinase that processes an initially biosynthesised precursor protein and is crucial for viral maturation and replication. Monophenyl and diphenyl pseudoxazolones were prepared by cyclisation-elimination of N-alpha-chloroacyl amino acids or by condensation of p-substituted benzamides with glyoxylic acid followed by dehydrative cyclisation. Such pseudoxazolones are good time-dependent inhibitors of the HAV and HRV 3C proteinases with IC50 values in the micromolar range. Mechanistic insights into the mode of inhibition of the pseudoxazolones were obtained from mass spectrometry and gHMQC NMR spectroscopy of the HAV 3C enzyme-inhibitor complex using a pseudoxazolone labelled at the alpha-carbon with C-13, 13b(alpha-C-13). The results indicate that HAV 3C proteinase was inactivated via the formation of a thioether bond by nucleophilic attack of the enzyme thiolate at the imine position of the pseudoxazolone 13b(alpha-C-13).
引用
收藏
页码:1351 / 1359
页数:9
相关论文
共 43 条
[1]   NEW SYNTHESIS OF N-ACYL AROMATIC ALPHA-AMINO-ACIDS - AMIDOALKYLATION OF AROMATIC AND HETEROCYCLIC-COMPOUNDS WITH GLYOXYLIC-ACID DERIVATIVES [J].
BENISHAI, D ;
SATATY, I ;
BERNSTEIN, Z .
TETRAHEDRON, 1976, 32 (13) :1571-1573
[2]   The refined crystal structure of the 3C gene product from hepatitis A virus: Specific proteinase activity and RNA recognition [J].
Bergmann, EM ;
Mosimann, SC ;
Chernaia, MM ;
Malcolm, BA ;
James, MNG .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2436-2448
[3]   Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis a virus (HAV) and implications for the polyprotein processing in HAV [J].
Bergmann, EM ;
Cherney, MM ;
Mckendrick, J ;
Frormann, S ;
Luo, C ;
Malcolm, BA ;
Vederas, JC ;
James, MNG .
VIROLOGY, 1999, 265 (01) :153-163
[4]  
BERGMANN EM, 1999, PROTEASES TARGETS TH
[5]   PURIFICATION OF RECOMBINANT HUMAN RHINOVIRUS-14-3C PROTEASE EXPRESSED IN ESCHERICHIA-COLI [J].
BIRCH, GM ;
BLACK, T ;
MALCOLM, SK ;
LAI, MT ;
ZIMMERMAN, RE ;
JASKUNAS, SR .
PROTEIN EXPRESSION AND PURIFICATION, 1995, 6 (05) :609-618
[6]  
Caplan JF, 2001, J CHEM SOC PERK T 1, P2217, DOI 10.1039/b105091p
[7]  
Cornforth J.W., 1949, CHEM PENICILLIN, P688
[8]   The synthesis and conformational aspects of a novel dioxopiperazine -: a possible β-turn constraint [J].
Davies, JS ;
Stelmach-Diddams, M ;
Fromentin, R ;
Howells, A ;
Cotton, R .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 2000, (02) :239-243
[9]   Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies [J].
Dragovich, PS ;
Webber, SE ;
Babine, RE ;
Fuhrman, SA ;
Patick, AK ;
Matthews, DA ;
Lee, CA ;
Reich, SH ;
Prins, TJ ;
Marakovits, JT ;
Littlefield, ES ;
Zhou, R ;
Tikhe, J ;
Ford, CE ;
Wallace, MB ;
Meador, JW ;
Ferre, RA ;
Brown, EL ;
Binford, SL ;
Harr, JEV ;
DeLisle, DM ;
Worland, ST .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2806-2818
[10]   Recent advances in the development of human rhinovirus 3C protease inhibitors [J].
Dragovich, PS .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (02) :177-184